Healthy.io

Healthy.io developed smartphone-enabled products to aid in the early diagnosis of chronic kidney disease, urinary tract infections and prenatal care.[4][6] Healthy.io’s urinalysis product became the first smartphone-based system to receive Food and Drug Administration clearance as a Class II clinical diagnostic device in 2018.[4] As part of the FDA approval process of the test to monitor for kidney disease, clinical trials showed the technology had equivalent accuracy to a professional laboratory.[4]

A peer-reviewed study in 2019 found the home-based urinalysis for early detection of kidney disease increased screening rates in patients with hypertension; 89% preferred testing at home.[7] A separate 2019 peer-reviewed study of home urinalysis self-testing amongst diabetic patients determined compliance rates were 72%.[8] Doctors in Britain used it in 2020 to monitor patients remotely during the COVID‑19 pandemic.[9][10]

The company had raised $95 million in funding as of June 2020.[11] In June 2020 the company acquired Silicon Valley competitor Inui Health for $9 million.[12][13]

Healthy.io's digital urinalysis products provide patients with at-home clinical-grade urinalysis.[3][4] Users scan the urinalysis dipstick using a smartphone app.[14] The technology then uses machine learning and computer vision techniques to correct the color - taking into account lighting conditions and other variables - to provide an analysis.[1][4]

The company's urinalysis products can be used to detect kidney damage, urinary tract infections, and pregnancy complications such as elevated protein levels.[15][3]

Its wound management product uses a smartphone app, calibration stickers, and web portal to measure and track chronic wounds over time. The app builds a 3D model of the wound for a more accurate assessment. As of 2020, the wound management product was being used by nurses in the U.S. and Britain.[16][17]